Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    "Bacterial Infections" | Mexico
Show Display Options
Rank Status Study
1 Completed BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis
Condition: Bacterial Infections
Interventions: Drug: Ciprofloxacin single dose;   Drug: Ciprofloxacin triple dose
2 Completed
Has Results
TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Condition: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: TR-701 FA;   Drug: Linezolid
3 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: ceftaroline;   Drug: vancomycin plus aztreonam;   Drug: Placebo
4 Recruiting Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium + Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
Condition: Bacterial Infections
Interventions: Drug: Imipenem+Cilastatin/Relebactam;   Drug: Colistimethate sodium (CMS);   Drug: Imipenem+Cilastatin;   Drug: Placebo to CMS
5 Completed Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™
Condition: Infections, Streptococcal
Interventions: Biological: Synflorix™ (3-Dose);   Biological: Synflorix™ (2-Dose);   Biological: Synflorix™ (Single Dose);   Biological: Prevenar 13 ™ (Single Dose);   Biological: Prevenar 13 ™ (2-Dose)
6 Completed
Has Results
A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection
Condition: Musculoskeletal Diseases
Intervention: Drug: No intervention
7 Completed
Has Results
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age
Condition: Pneumococcal Disease
Interventions: Biological: Synflorix;   Biological: Infanrix hexa;   Biological: Rotarix
8 Completed Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Skin Structures and Soft Tissue Infections
Interventions: Drug: delafloxacin;   Drug: vancomycin;   Drug: aztreonam
9 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: IV Vancomycin plus IV Aztreonam;   Drug: Ceftaroline
10 Completed
Has Results
Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
Conditions: Bacterial Infections;   Diabetic Foot;   Osteomyelitis
Interventions: Drug: Tigecycline;   Drug: Ertapenem
11 Completed Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers
Condition: Meningococcal Infection
Interventions: Biological: Meningococcal vaccine GSK 134612;   Biological: SynflorixTM;   Biological: Infanrix-IPV/HiberixTM
12 Completed Vitamin D Supplementation Enhances Immune Response to Bacille-Calmette-Guerin (BCG) Vaccination in Infants
Condition: Tuberculosis
Intervention: Dietary Supplement: Vitamin D3 (cholecalciferol)
13 Unknown  Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus Reuteri
Conditions: Helicobacter Pylori Infection;   Dyspepsia
Interventions: Dietary Supplement: Lactobacillus reuteri;   Dietary Supplement: Placebo
14 Completed Treatment of Latent Tuberculosis Infection With Isoniazid
Condition: Tuberculosis
Interventions: Drug: Isoniazid;   Drug: isoniazid
15 Terminated Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
16 Completed
Has Results
13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico
Condition: Pneumococcal Infections
Intervention: Biological: vaccine-13vPnC
17 Completed Expression of Tuberculosis in the Lung
Condition: Tuberculosis
Intervention: Other: Bronchoalveolar lavages and venipunctures only
18 Completed Rapid Characterization of Paucibacillary TB Along Tex/Mex Border
Condition: Mycobacterium Tuberculosis
Intervention:
19 Completed Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
Conditions: Diphtheria;   Tetanus;   Acellular Pertussis
Interventions: Biological: Boostrix TM (new syringe presentation);   Biological: Boostrix TM (previous syringe presentation)
20 Completed Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
Condition: Skin Infections, Bacterial
Intervention: Drug: SB-275833 ointment, 1%

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.